4//SEC Filing
de Verneuil Vanina 4
Accession 0001628280-25-050592
CIK 0001706431other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 3:27 PM ET
Size
4.8 KB
Accession
0001628280-25-050592
Insider Transaction Report
Form 4
de Verneuil Vanina
EVP and General Counsel
Transactions
- Sale
Common Stock
2025-11-05$5.16/sh−2,385$12,307→ 78,210 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2024.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0002036234
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 3:27 PM ET
- Size
- 4.8 KB